Gugulipid 340 mg™
Other CombinationsBrand: PL Progressive Laboratories
Net Contents
90 Vegetable Capsule(s)
Serving Size
1 Vegetable Capsule(s)
Servings Per Container
Not specified
Supplement Form
Capsule
Bar Code (UPC/SKU)
3 51821 00462 4
Product Version
Reorder No. 462 Rev. A0814
Label Analysis
Objective insights generated automatically from the official DSLD label — a quick, factual read of how this product is formulated and disclosed.
2 distinct active ingredients are disclosed in Supplement Facts.
Every active ingredient discloses a specific amount per serving.
Label states: Vegetarian.
This analysis is generated algorithmically from label data for educational reference only. It is not a product endorsement, ranking, or medical advice.
Supplement Facts
Serving Size: 1 Vegetable Capsule(s) · 1– per day
| Ingredient | Amount Per Serving | |
|---|---|---|
| Gugulipid extract | 340 mg | — |
| Guggulsterones(Gugulipid extract) | 9 mg | — |
Not Present
Other Ingredients
Target Groups
Label Claims
Directions & Suggested Use
Suggested/Recommended/Usage/Directions
Directions: One vegetable capsule with each meal, or more, as directed by a health care professional.
Warnings & Precautions
Precautions re: All Other
Tamper evident band around cap and seal on bottle. Do not use if either seal is broken or missing.
Precautions re: Children
Keep out of reach of children.
Formulation
Formulation re: Does NOT Contain
This product is free of artificial colors, flavors, preservatives and sodium. Contains no animal products.
Formulation re: Vegetarian/Vegan
Contains no animal products.
FDA Statements
FDA Statement of Identity
Dietary Supplement
Other Label Statements
Brand IP Statement(s) re: (c), (TM), (SM)
Gugulipid is a registered trademark of Sabinsa corp.
General Statements: All Other Content
Standardized extract
General Statements: All Other Content
Sold only for dispensing by a licensed health care professional.
General Statements: All Other Content
Progressive Laboratories manufactured this product in its 3rd party GMP-inspected facility. (Good Manufacturing Practices)
General: Product/Version Code
Rev. A0814 Reorder No. 462
Seals/Symbols
GMP 3rd party confirmed compliant
Brand IP Statement(s) re: (c), (TM), (SM)
Science + therapeutic potency = results
General Statements: All Other Content
PL Since 1972
Manufacturer & Distributor
Manufacturer
Progressive Laboratories, Inc.
1701 W. Walnut Hill Ln., Irving, Texas, 75038
Market Reference
Gugulipid Progressive Labs 90 Capsules
Supplement First5.0(3)$38.00Progressive Labs Poligugul Complex 90 Capsules
Professional Supplement Center$42.99Planet Ayurveda Gugulipid Capsules 60 Caps
Distacart$32.78LowestProgressive Labs Poligugul Complex Supplement 90 Count
GoSupps.com$89.99
Where to Buy Locally
Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.
Showing representative supplement & health retailers — search above for stores in your area.
The Vitamin Shoppe
4.6 (242)Vitamin & supplements store
2201 E Fowler Ave A, Tampa, FL 33612
NutriVita Suplementos
4.7 (51)Vitamin & supplements store
168 SE 1st St #502a, Miami, FL 33131
National Nutrition
4.8 (1264)Vitamin & supplements store
5 Progress Dr, Orillia, ON L3V 0T7, Canada
Research & Studies
Prime Ayurvedic plant drugs
S Dev - 2023 - books.google.com
… bestow their health reviving quality for the perfect health of … n order to place the work covered in this book in a proper … Gugulipid was cleared for registration in India in 1986, and the …
202328 citationsKey articles related to complementary and alternative medicine in cardiovascular disease: part 1
SL Chow, MP Dorsch, SP Dunn… - … : The Journal of …, 2010 - Wiley Online Library
… both guggulipid … guggulipid, while there were none in the placebo group. Despite many preliminary studies published in the Indian medical literature supporting the use of guggulipid …
20104 citationsIntegrating complementary medicine into cardiovascular medicine: a report of the american college of cardiology foundation task force on clinical expert consensus …
JHK Vogel, SF Bolling, RB Costello… - Journal of the American …, 2005 - jacc.org
… In the first randomized, controlled trial of guggulipid outside of India, 103 healthy adults with hypercholesterolemia given 1,000 or 2,000 mg guggulipid containing 2.5% guggulsterones …
2005188 citationsGugulipid causes hypercholesterolemia leading to endothelial dysfunction, increased atherosclerosis, and premature death by ischemic heart disease in male mice
A Leiva, S Contreras-Duarte, L Amigo, E Sepúlveda… - PLoS …, 2017 - journals.plos.org
… show important adverse effects of gugulipid intake on HDL … deleterious effects on cardiovascular health in humans. In … , 340 U/ml cholesterol oxidase, and 0.058 U/mg peroxidase) …
201712 citationsCholesterol lowering effects of bovine serum immunoglobulin in human participants with mild hypercholesterolemia
ML Black - 2006 - oaktrust.library.tamu.edu
… Tim Church who served as medical director for this project and assisted in the … of the guggulipid capsules. Final study comments noted that, at 36 weeks, the effect of diet and guggulipid …
2006Fundamentals of membrane lipid replacement: a natural medicine approach to repairing cellular membranes and reducing fatigue, pain, and other symptoms …
GL Nicolson, G Ferreira de Mattos, M Ash, R Settineri… - Membranes, 2021 - mdpi.com
… Membrane Lipid Replacement (MLR) uses natural membrane lipid supplements to safely … , decrease symptoms and improve health. Oral MLR supplements contain mixtures of cell …
202126 citations
Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2017-03-24. DSLD Label ID: 71417. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.
Related Products
01-02 Enhanced Fat Melting Matrix
ATS Labs
1000 mg Vitamin C Acai Berry
Emergen-C
1000 mg Vitamin C Cranberry Pomegranate
Emergen-C
1000 MG Vitamin C Cranberry-Pomegranate
Emergen-C